As a leader in Contract Development and Manufacturing, Lonza Pharma & Biotech is recognised for high quality service, global capacity, an innovative tech platform and extensive experience.
Lonza has a broad expertise in biologics, small molecules, bio-conjugates and cell & gene therapy, supporting pre-clinical stage through to commercialisation, for both drug substance and drug product. Orla McGarvey is Principal Group Leader in Lonza’s Drug Product Services Division, supporting DP Process Development.
Orla’s career to date in the pharmaceutical and biotech industry spans over 16 years working in the field of formulation and drug product development, with extensive experience in lyo cycle development, scale up and tech transfer while working in the USA with the world’s leading experts and pioneers in the field of freeze-drying.